EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interaction of Receptor-Binding Domain of the SARS-CoV-2 Omicron Variant with hACE2 and Actin

Ai Fujimoto iD, Haruki Kawai, Rintaro Kawamura, Akira Kitamura iD

Cells · 2024

DOI: 10.3390/cells13161318 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Ai Fujimoto und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cellular and Molecular Sciences, Graduate School of Life Science, Hokkaido University, N21W11, Kita-ku, Sapporo 001-0021, Hokkaido, Jap…. Hauptthemen laut MEDLINE: SARS-CoV-2, Angiotensin-Converting Enzyme 2, Spike Glycoprotein, Coronavirus, Protein Binding. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, Japan Science and Technology Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified in 2021 as a variant with heavy amino acid mutations in the spike protein, which is targeted by most vaccines, compared to previous variants. Amino acid substitutions in the spike proteins may alter their affinity for host viral receptors and the host interactome. Here, we found that the receptor-binding domain (RBD) of the omicron variant of SARS-CoV-2 exhibited an increased affinity for human angiotensin-converting enzyme 2, a viral cell receptor, compared to the prototype RBD. Moreover, we identified β- and γ-actin as omicron-specific binding partners of RBD. Protein complex predictions revealed that many omicron-specific amino acid substitutions affected the affinity between RBD of the omicron variant and actin. Our findings indicate that proteins localized to different cellular compartments exhibit strong binding to the omicron RBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Angiotensin-Converting Enzyme 2Spike Glycoprotein, CoronavirusProtein BindingActinsHumansCOVID-19Protein DomainsMutationAmino Acid SubstitutionReceptors, VirusBinding Sites

Stichwörter der Autor:innen

COVID-19actinfluorescence correlation spectroscopyprotein–protein interactionspike protein

Substanzen

Angiotensin-Converting Enzyme 2Spike Glycoprotein, CoronavirusACE2 protein, humanspike protein, SARS-CoV-2ActinsReceptors, Virus

Autor:innen und Institutionen

  • Laboratory of Cellular and Molecular Sciences, Graduate School of Life Science, Hokkaido University, N21W11, Kita-ku, Sapporo 001-0021, Hokkaido, Japan.
  • Laboratory of Cellular and Molecular Sciences, Faculty of Advanced Life Science, Hokkaido University, N21W11, Kita-ku, Sapporo 001-0021, Hokkaido, Japan.
  • PRIME, Japan Agency for Medical Research and Development, Chiyoda-ku, Tokyo 100-0004, Japan.

ORCID-Profile: Ai Fujimoto, Akira Kitamura

Förderung

  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development
  • Japan Science and Technology Agency
  • Japan Society for Promotion of Science (JSPS)
  • Hokkaido University Office for Developing Future Research Leaders (L-Station)
  • Nakatani and Hoansha Foundations
  • Japan Science and Technology Agency (JST) of Hokkaido University

Zitieren

APA

Fujimoto, A., Kawai, H., Kawamura, R., & Kitamura, A. (2024). Interaction of Receptor-Binding Domain of the SARS-CoV-2 Omicron Variant with hACE2 and Actin. Cells. https://doi.org/10.3390/cells13161318

Vancouver

Fujimoto A, Kawai H, Kawamura R, Kitamura A. Interaction of Receptor-Binding Domain of the SARS-CoV-2 Omicron Variant with hACE2 and Actin. Cells. 2024. doi:10.3390/cells13161318

BibTeX
@article{Fujimoto2024,
  author = {Fujimoto, Ai and Kawai, Haruki and Kawamura, Rintaro and Kitamura, Akira},
  title = {Interaction of Receptor-Binding Domain of the SARS-CoV-2 Omicron Variant with hACE2 and Actin},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13161318}
}
Kostenlos starten →